OpenEvidence vs Verge Genomics
Which Healthcare AI tool is better in 2026?
OpenEvidence
AI medical assistant for clinicians
Verge Genomics
We use human data and AI to develop better drugs faster
Side-by-side
OpenEvidence is the more established option (raised $735M); pricing is comparable on both sides.
| Metric | OpenEvidence | Verge Genomics |
|---|---|---|
| Taglinei | AI medical assistant for clinicians | We use human data and AI to develop better drugs faster |
| Foundedi | 2022 | 2015🏆 |
| HQi | San Francisco, US | San Francisco, US |
| Employeesi | 50-200 | 11-50🏆 |
| Neuron scorei | 63🏆 | 47 |
| Total fundingi | $735M🏆 | $98.5M |
| Latest roundi | Series D · Jan 2026 | Series B · Dec 2021 |
| Valuationi | $12B🏆 | — |
| Cheapest paid plani | — | Pricing not disclosed |
| Free plani | ✗ | ✗ |
| Free triali | ✗ | ✗ |
| Top tier pricei | Enterprise · Contact sales | Pricing not disclosed |
| Pricing summaryi | 1 published plans | Pricing not listed |
| Categoriesi |
Capability matrix
Developer-facing capabilities and access signals for OpenEvidence and Verge Genomics.
| Capability | OpenEvidence | Verge Genomics |
|---|---|---|
| MCP support | ✗ | ✗ |
| Public API | ✓ | ✗ |
| Webhooks | ✗ | ✗ |
| OAuth 2.0 | ✗ | ✗ |
| SDK languages | 2 (TypeScript, Python) | — |
| Free plan | ✗ | ✗ |
| Free trial | ✗ | ✗ |
| Verified | ✓ | ✗ |
| Active deal | ✗ | ✗ |
🟢 Strengths of OpenEvidence
- Has raised more capital ($735M vs $98.5M)
- Higher Neuron score (63 vs 47)
- Newer company (2022)
- Verified profile
🔵 Strengths of Verge Genomics
- More mature (2015)
Which should you choose?
Choose Verge Genomics if price matters most — it starts at Pricing not listed, which is friendlier for teams watching burn. Both AI Healthcare tools ship core features, so the cost delta often decides it for small teams and solo operators.
Choose OpenEvidence if you want the most established option — it has raised $735M, suggesting more runway for enterprise features, support, and long-term roadmap. For mission-critical workflows or larger teams, that stability often outweighs a lower monthly price.
Frequently asked questions
OpenEvidence vs Verge Genomics — which is better?
It depends on your priority. OpenEvidence has raised more capital and is the more established option; Verge Genomics has broader feature depth. See the side-by-side table above.
Is OpenEvidence cheaper than Verge Genomics?
No — Verge Genomics's cheapest paid plan is Pricing not listed, while OpenEvidence's is Freemium.
Do OpenEvidence and Verge Genomics offer free plans?
OpenEvidence: Paid only. Verge Genomics: Paid only.
Explore more AI Healthcare tools
Contextual paths to related AI startups, deals and rankings.